ALPL and breast cancer: Among the osteogenic markers, ES BC (set) consistently showed the strongest upregulation at both time points, particularly for ALPL, RUNX2, and COL1A1, all of which reached significantly higher levels than those observed with AH Plus Bioceramic Sealer and the control (p < 0.01 to <0.001).